Print

One Lambda, Inc., Now Part of Thermo Fisher Scientific (TMO), Obtained FDA Clearance for HLA Fusion Software Version 3.0  
1/24/2013 8:53:53 AM

CANOGA PARK, Calif.--(BUSINESS WIRE)--One Lambda, Inc., now part of Thermo Fisher Scientific, a leading producer of medical diagnostic products for the HLA transplant community, is pleased to announce that HLA Fusion Software version 3.0, a companion software to molecular typing and antibody screening products, has obtained FDA clearance by the FDA and a Health Canada License by the Ministry of Health Canada. All of One Lambda software products are designed to assist personnel experienced in HLA analysis by suggesting typing and antibody screening results. Product families used in conjunction with HLA Fusion include the market-leading LABScreen® (antibody detection) and LABType® (HLA Typing) products, in addition to LAT™, LCT™, FlowPRA®, and MicroSSP™ products. The HLA Fusion Software version 3.0 provides all the tools and applications from version 2.0 and its related Service Packs, support with Luminex® xPONENT® 3.1 acquisition software for LABScan® 100, and more.
//-->